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Variable Clinical Presentations of Left Atrial Myxoma in
Malaysia: A Case Series
PX Kuan,1 HS Ling,2 K Andrew,3 AYY Fong1,3
1Clinical Research Centre, Sarawak General Hospital; 2Department of
Medicine, Sarawak General Hospital; 3Department of Cardiology, Sarawak
Heart Centre, Malaysia
Introduction and Purpose: Cardiac myxoma is the most common primary
tumour of the heart; often missed due to non-specific symptoms. It may lead
to disastrous outcome if it is not treated in a symptomatic patient.
Transthoracic echocardiogram (TTE) is the usual imaging modality for
establishing the diagnosis.
Methods: We reviewed the different types of presentations and outcomes of
patients presented to Sarawak General Hospital, Malaysia with myxoma in
2015.
Results: Case One: A 67-year-old gentleman, initially treated as bronchial
asthma, referred to our centre for worsening shortness of breath despite being
treated for one week. Chest X-ray (CXR) was unremarkable. Further work-
up with TTE showed left atrial mass suggestive of myxoma measuring
4.3 cm x 3.8 cm. Case Two: A 38-year-old lady, with history of ischemic
stroke, presented with sudden unilateral limb weakness and fever. No
significant neurological deficit but peripheral vasculitic lesions were noted.
She was initially investigated for infective endocarditis with embolic event.
However, repeated TTE in our centre showed left atrial mass suggestive of
myxoma, measuring 2.1 cm x 2.7 cm. Case Three: A 73-year-old previously
healthy woman, presented with worsening reduced effort tolerance over the
past one month. Examination was suggestive of left heart failure; consistent
with CXR findings. Initial TTE showed atrial mass (1.4 cm x 7.2 cm) causing
mitral valve obstruction and pulmonary hypertension.
Discussion/Conclusion: The diagnosis of atrial myxoma can be ambiguous
and may be easily missed, especially when the different clinical presentations
are suggestive of other diagnoses. TTE is investigation of choice for
diagnosing myxoma in symptomatic patients. Early surgical intervention is
warranted for better outcome. Our review showed all tumour excisions were
successful and histopathological examinations confirmed myxoma. Although
myxoma is histopathologically benign, they can lead to serious complications
e.g. embolism and intracardiac obstruction.
CARDIAC IMAGING
Targeted Delivery of Hydrogen Sulfide by Ultrasound Mediated
Microbubble Destruction Alleviates Myocardial Ischemia-
reperfusion Injury
GB Chen, J Liu, L Yang, JP Bin, JF Wu
Department of Cardiology, Nanfang Hospital, Southern Medical University,
China
Background: Hydrogen sulfide (H2S) is an attractive agent for myocardial
ischemia-reperfusion injury, however, systemic delivery of H2S may cause
unwanted side effects. Ultrasound mediated microbubble destruction has
become a promising tool for organ specific delivery of bioactive substance.
We hypothesized that intravenous administration of microbubbles
encapsulating H2S gas combined with ultrasound exposure permit local release
of H2S and alleviates myocardial ischemic-reperfusion injury.
Methods: We developed and characterized microbubbles carrying hydrogen
sulfide (hs-MB) with different H2S/C3F8 ratios (4/0, 3/1, 2/2, 1/3, 0/4) and
determined the optimal ratio. Release of H2S trigger by ultrasound was
investigated in vitro. In a rodent model of myocardial ischemia-reperfusion
injury, hs-MB were administered intravenously with ultrasound applied over
the heart. Infarct size was determined by evans blue and TTC staining. Left
ventricular structure and function was assessed by echocardiography.
Results: The H2S/C3F8 ratio of 2/2 was found to be an optimal ratio to prepare
stable hs-MB with higher H2S loading capability. The concentration of the
hs-MB decreased while the dissolved H2S increased significantly after
exposure to ultrasound. Ultrasound targeted hs-MB destruction limited the
extent of myocardial injury and preserved left ventricular function. No
significant hemodynamic changes were observed during ultrasound mediated
hs-MB destruction.
Conclusions: Delivery of H2S by ultrasound mediated microbubble
destruction limits the extent of myocardial ischemia-reperfusion injury. This
may provide a noninvasive strategy for targeted delivery of a therapeutic gas
to protect myocardial injury from ischemia-reperfusion, avoiding systemic
side effects.
